The Enterprise Value as of December 2025 (TTM) for Phathom Pharmaceuticals, Inc. (PHAT) is 913.24M

According to Phathom Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 913.24M. This represents a change of 16.47% compared to the average of 784.10M of the last 4 quarters.

Phathom Pharmaceuticals, Inc. (PHAT) Historical Enterprise Value (quarterly & annually)

How has PHAT Enterprise Value performed in the past?

The mean historical Enterprise Value of Phathom Pharmaceuticals, Inc. over the last ten years is 520.06M. The current 913.24M Enterprise Value has changed 17.46% with respect to the historical average. Over the past ten years (40 quarters), PHAT's Enterprise Value was at its highest in in the March 2021 quarter at 1.17B. The Enterprise Value was at its lowest in in the March 2018 quarter at 0.

Phathom Pharmaceuticals, Inc. (PHAT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Phathom Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Phathom Pharmaceuticals, Inc. (PHAT) Average Enterprise Value

How has PHAT Enterprise Value performed in the past?

The current Enterprise Value of Phathom Pharmaceuticals, Inc. (PHAT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Phathom Pharmaceuticals, Inc. (PHAT) Enterprise Value vs. Peers

How is PHAT’s Enterprise Value compared to its peers?

Phathom Pharmaceuticals, Inc.’s Enterprise Value is less than Nurix Therapeutics, Inc. (1.36B), less than Kodiak Sciences Inc. (1.30B), less than Xencor, Inc. (1.46B), less than UroGen Pharma Ltd. (1.17B), greater than Bicara Therapeutics Inc. Common Stock (593.30M), greater than Oculis Holding AG (765.69M), greater than BridgeBio Oncology Therapeutics Inc. (517.22M), greater than Septerna, Inc. (875.41M), less than Sana Biotechnology, Inc. (1.39B), less than AnaptysBio, Inc. (1.10B),

Build a custom stock screener for Phathom Pharmaceuticals, Inc. (PHAT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phathom Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Phathom Pharmaceuticals, Inc. (PHAT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Phathom Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.